Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

Drug treatment could suppress cancer cells in the brain

The growth of brain tumor initiating cells positively linked to glioma development and recurrence may be altered by an immunotherapy, according to a study published online Dec. 8 by Nature Neuroscience.

Lymphoseek lands FDA fast track

Navidea Biopharmaceuticals, makers of technetium-99m tilmanocept injection, otherwise known as Lymphoseek, announced FDA status for fast-track approval for the detection of lymph node involvement in head and neck cancers, according to a statement Dec. 10.

Prostate cancer patients live longer by combining chemo with hormone therapies

Preliminary results of a clinical trial for the chemotherapy drug docetaxel indicate that hormone-sensitive metastatic prostate cancer patients who added hormone therapy to the mix experienced significantly prolonged survival, according to a Dec. 5 statement by the National Institutes of Health (NIH).

Novel agent emerges for early Parkinson’s

A new imaging agent is showing potential for the early detection of Parkinson’s disease (PD) by identifying a functional loss of dopamine neurons, according to a study published online Nov. 28 by the Journal of Nuclear Medicine.

Molecular imaging device market expected to rise to $3B by 2018

The current global market for molecular imaging technology is estimated at $2.2 billion this year and is expected to increase at a compound annual growth rate of 6.2 percent, according to a November 2013 market research report from BCC Research.

Radiology’s Gut Check

You know things are bad when virtually all of the luminaries and thought leaders in a profession agree on certain negative indicators and a most likely scenario that will be the result of a confluence of “perfect storm” issues. That’s how it is with radiology these days. Lots of influential people in this space agree that change is here to stay, that it is mostly going to hurt, and that it is long overdue.

Thumbnail

Estimated Alzheimer's spikes to 135 million by 2050

New data regarding the prevalence of Alzheimer's disease is looming far and above previous estimates: 17 percent higher than previously thought, according to statistics from Alzheimer's Disease International.

RSNA: Amyloid studies ‘disappointing’

CHICAGO--The quest for a clear way forward in neurodegenerative imaging and therapeutics continues, with many of the same challenges continuing from previous years, according to a neuroimaging symposium during the Radiological Society of North America’s (RSNA) 99th annual meeting.